Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-25

Clinical Trial Update: BOLT Lithotripsy RESTORE BTK Trial [NA]

View source ↗

Summary

The RESTORE BTK trial evaluating BOLT Lithotripsy by Bolt Medical for peripheral arterial disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BOLT Lithotripsy RESTORE BTK

Snippet

Sponsor: Bolt Medical | Conditions: Peripheral Arterial Disease, Peripheral Vascular Disease | NA | Status: COMPLETED